TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited May 28, 1976
TCL Archive Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded April 10, 1998